2024-05-07

#reports #WAT

[Waters](https://eninvs.com/all.php?name=WAT) (Research instrument manufacturer) reported for [2024 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=167916)
(2024-05-07, Before Market Open):

- Revenue -7.0% YoY (vs -4.7% in previous quarter and historical rate +5.7%)
- EBITDA -11.2% YoY (vs -1.9% in previous quarter and historical rate +3.6%)
- EBITDA margin 28.6% decreased compared to 29.9% same period last year
- Net Debt decreased by $151.0 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) -$0.8 bln (negative), 4.3% of market cap
- EV/EBITDA multiple is 21.6x compared to historical level (75th percentile) of 22.4x
- EV/Sales multiple is 7.1x

The company showed EPS +$1.72 per share. At the opening of the session the share price went down -0.1% vs S&P500 +0.1%

------------------------------------------------

2024-05-07

#reports #UE

[Urban Edge Properties](https://eninvs.com/all.php?name=UE) (REIT — Diversified) reported for [2024 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=167913)
(2024-05-07, Before Market Open):

- Revenue +11.1% YoY (vs +14.7% in previous quarter and historical rate +10.4%)
- EBITDA +200.0% YoY (vs +40.8% in previous quarter and historical rate +40.9%)
- EBITDA margin 54.5% increased compared to 20.2% same period last year
- EV/EBITDA multiple is 8.5x compared to historical level (75th percentile) of 17.1x
- EV/Sales multiple is 4.7x

At the opening of the session the share price went up +2.5% vs S&P500 +0.1%

------------------------------------------------

2024-05-07

#reports #TACT

[TransAct Technologies](https://eninvs.com/all.php?name=TACT) (Computer Hardware) reported for 2024 q1
(2024-05-07, Before Market Open):

- Revenue -50.0% YoY (vs -27.8% in previous quarter and historical rate +38.5%)
- EBITDA -125.0% YoY (vs -50.0% in previous quarter)
- EBITDA margin -9.1% decreased compared to 18.2% same period last year
- Net Debt increased by $2.0 mln over the past reporting period (3.9% of market cap)
- FCF (LTM) +$0.0 bln (positive), 9.8% of market cap
- EV/EBITDA multiple is 6.6x compared to historical level (75th percentile) of 11.2x
- EV/Sales multiple is 0.7x

At the opening of the session the share price went down -21.2% vs S&P500 +0.1%

------------------------------------------------

2024-05-07

#reports #STIM

[Neuronetics](https://eninvs.com/all.php?name=STIM) (Diagnostics and Research) reported for 2024 q1
(2024-05-07, Before Market Open):

- Revenue +6.3% YoY (vs +11.1% in previous quarter and historical rate +14.4%)
- EBITDA margin -35.3% increased compared to -56.3% same period last year
- Net Debt increased by $12.0 mln over the past reporting period (11.0% of market cap)
- FCF (LTM) -$0.0 bln (negative), 15.6% of market cap
- EV/Sales multiple is 1.7x

At the opening of the session the share price went down -24.3% vs S&P500 +0.1%

------------------------------------------------

2024-05-07

#reports #SQSP

[Squarespace, Inc.](https://eninvs.com/all.php?name=SQSP) (Software — Infrastructure) reported for 2024 q1
(2024-05-07, Before Market Open):

- Revenue +18.6% YoY (vs +18.3% in previous quarter and historical rate +14.3%)
- EBITDA -55.6% YoY (vs +3600.0% in previous quarter and historical rate +47.5%)
- EBITDA margin 1.4% decreased compared to 3.8% same period last year
- Net Debt decreased by $968.0 mln over the past reporting period (19.7% of market cap)
- FCF (LTM) -$0.0 bln (negative), 0.2% of market cap
- EV/EBITDA multiple is 44.1x compared to historical level (75th percentile) of 237.1x
- EV/Sales multiple is 5.0x

At the opening of the session the share price went up +2.8% vs S&P500 +0.1%

------------------------------------------------

2024-05-07

#reports #SPR

[Spirit AeroSystems](https://eninvs.com/all.php?name=SPR) (Commercial aircraft structures manufacturer) reported for 2024 q1
(2024-05-07, Before Market Open):

- Revenue +19.0% YoY (vs +37.3% in previous quarter and historical rate +25.7%)
- EBITDA margin -26.3% decreased compared to -1.0% same period last year
- Net Debt increased by $456.0 mln over the past reporting period (12.4% of market cap)
- FCF (LTM) -$0.0 bln (negative), 0.5% of market cap
- EV/Sales multiple is 1.2x

At the opening of the session the share price went down -1.4% vs S&P500 +0.1%

------------------------------------------------

2024-05-07

#reports #SNCY

[Sun Country Airlines Holdings, Inc.](https://eninvs.com/all.php?name=SNCY) (Airlines) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=SNCY&q=2024 q1&id=778801)
(2024-05-06, Before Market Open):

- Revenue +14.8% YoY (vs +21.2% in previous quarter and historical rate +40.9%)
- EBITDA +2.6% YoY (vs +17.1% in previous quarter and historical rate +53.8%)
- EBITDA margin 25.4% decreased compared to 28.4% same period last year
- EV/EBITDA multiple is 3.2x compared to historical level (75th percentile) of 12.6x
- EV/Sales multiple is 0.7x

The company showed EPS +$0.64 per share. At the opening of the session the share price went up +0.7% vs S&P500 +0.3%

------------------------------------------------

2024-05-07

#reports #SCSC

[ScanSource](https://eninvs.com/all.php?name=SCSC) (Scanner supplier) reported for 2024 q1
(2024-05-07, Before Market Open):

- Revenue -15.0% YoY (vs -12.5% in previous quarter and historical rate +23.3%)
- EBITDA -39.0% YoY (vs -26.1% in previous quarter and historical rate +52.2%)
- EBITDA margin 3.3% decreased compared to 4.6% same period last year
- Net Debt decreased by $137.0 mln over the past reporting period (12.4% of market cap)
- FCF (LTM) +$0.2 bln (positive), 13.6% of market cap
- EV/EBITDA multiple is 5.4x compared to historical level (75th percentile) of 7.1x
- EV/Sales multiple is 0.2x

At the opening of the session the share price went up +6.4% vs S&P500 +0.1%

------------------------------------------------

2024-05-07

#reports #RYTM

[Rhythm Pharmaceuticals](https://eninvs.com/all.php?name=RYTM) (Molecular drug manufacturer) reported for 2024 q1
(2024-05-07, Before Market Open):

- Revenue +136.4% YoY (vs +166.7% in previous quarter and historical rate +175.3%)
- EBITDA margin -534.6% decreased compared to -472.7% same period last year
- Net Debt increased by $74.0 mln over the past reporting period (2.8% of market cap)
- FCF (LTM) -$0.0 bln (negative), 0.7% of market cap
- EV/Sales multiple is 26.1x

At the opening of the session the share price went down -13.7% vs S&P500 +0.1%

------------------------------------------------

2024-05-07

#reports #PMTS

[CPI Card Group](https://eninvs.com/all.php?name=PMTS) (Credit Services) reported for [2024 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=167909)
(2024-05-07, Before Market Open):

- Revenue -7.4% YoY (vs -18.3% in previous quarter and historical rate +13.4%)
- Net Income -54.5% YoY (vs -75.0% in previous quarter and historical rate +46.7%)
- Net Income margin 4.5% decreased compared to 9.1% same period last year
- P/E multiple is 11.2x compared to historical level (75th percentile) of 9.0x
- P/S multiple is 0.5x
- Price to book: -4.0x

At the opening of the session the share price went up +2.1% vs S&P500 +0.1%

------------------------------------------------

2024-05-07

#reports #OTTR

[Otter Tail](https://eninvs.com/all.php?name=OTTR) (Energy provider) reported for 2024 q1
(2024-05-06, After Market Close):

- Revenue +2.4% YoY (vs +4.3% in previous quarter and historical rate +16.5%)
- EBITDA +15.2% YoY (vs +21.8% in previous quarter and historical rate +33.3%)
- EBITDA margin 34.9% increased compared to 31.0% same period last year
- Net Debt increased by $30.0 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) +$0.1 bln (positive), 2.0% of market cap
- EV/EBITDA multiple is 9.5x compared to historical level (75th percentile) of 10.3x
- EV/Sales multiple is 3.3x

At the opening of the session the share price went up +5.3% vs S&P500 +0.1%

------------------------------------------------

2024-05-07

#reports #OSCR

[Oscar Health, Inc.](https://eninvs.com/all.php?name=OSCR) (Healthcare Plans) reported for 2024 q1
(2024-05-07, Before Market Open):

- Revenue +45.7% YoY (vs +43.9% in previous quarter and historical rate +85.8%)
- Net Income margin 8.3% increased compared to -2.7% same period last year
- P/S multiple is 0.6x
- Price to book: 5.2x

At the opening of the session the share price went up +4.1% vs S&P500 +0.1%

------------------------------------------------

2024-05-07

#reports #OFIX

[Orthofix Medical](https://eninvs.com/all.php?name=OFIX) (Medical equipment manufacturer) reported for [2024 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=167925)
(2024-05-07, Before Market Open):

- Revenue +8.0% YoY (vs +63.9% in previous quarter and historical rate +27.2%)
- EBITDA margin -5.8% increased compared to -32.0% same period last year
- EV/Sales multiple is 0.7x

At the opening of the session the share price went down -2.3% vs S&P500 +0.1%

------------------------------------------------

2024-05-07

#reports #NRG

[NRG Energy](https://eninvs.com/all.php?name=NRG) (Energy services provider) reported for 2024 q1
(2024-05-07, Before Market Open):

- Revenue -3.8% YoY (vs -50.4% in previous quarter and historical rate +46.1%)
- EBITDA margin 15.3% increased compared to -17.5% same period last year
- Net Debt decreased by $358.0 mln over the past reporting period (1.9% of market cap)
- FCF (LTM) +$0.9 bln (positive), 4.7% of market cap
- EV/EBITDA multiple is 7.5x compared to historical level (75th percentile) of 7.5x
- EV/Sales multiple is 1.0x

At the opening of the session the share price went up +4.8% vs S&P500 +0.1%

------------------------------------------------

2024-05-07

#reports #NOVT

[Novanta](https://eninvs.com/all.php?name=NOVT) (Scientific and Technical Instruments) reported for 2024 q1
(2024-05-07, Before Market Open):

- Revenue +5.5% YoY (vs -2.8% in previous quarter and historical rate +15.0%)
- EBITDA +2.6% YoY (vs -15.4% in previous quarter and historical rate +17.7%)
- EBITDA margin 16.9% decreased compared to 17.4% same period last year
- Net Debt increased by $176.0 mln over the past reporting period (3.0% of market cap)
- FCF (LTM) -$0.1 bln (negative), 1.4% of market cap
- EV/EBITDA multiple is 40.3x compared to historical level (75th percentile) of 45.2x
- EV/Sales multiple is 7.0x

At the opening of the session the share price went up +2.3% vs S&P500 +0.1%

------------------------------------------------

2024-05-07

#reports #NJR

[New Jersey Resources Corporation](https://eninvs.com/all.php?name=NJR) (Energy company) reported for 2024 q1
(2024-05-07, Before Market Open):

- Revenue +2.2% YoY (vs -35.5% in previous quarter and historical rate +4.0%)
- EBITDA +3.4% YoY (vs -15.4% in previous quarter and historical rate +10.9%)
- EBITDA margin 31.9% increased compared to 31.5% same period last year
- EV/EBITDA multiple is 8.2x compared to historical level (75th percentile) of 15.9x
- EV/Sales multiple is 2.5x

At the opening of the session the share price went down -0.4% vs S&P500 +0.1%

------------------------------------------------

2024-05-07

#reports #MKTX

[MarketAxess](https://eninvs.com/all.php?name=MKTX) (Bond trading platform) reported for 2024 q1
(2024-05-07, Before Market Open):

- Revenue +3.4% YoY (vs +10.7% in previous quarter and historical rate +2.1%)
- Net Income -1.4% YoY (vs +18.6% in previous quarter and historical rate -14.6%)
- Net Income margin 34.8% decreased compared to 36.5% same period last year
- P/E multiple is 30.5x compared to historical level (75th percentile) of 36.9x
- P/S multiple is 10.2x
- Price to book: 6.0x

At the opening of the session the share price went up +1.5% vs S&P500 +0.1%

------------------------------------------------

2024-05-07

#reports #ITCI

[Intra-Cellular Therapies](https://eninvs.com/all.php?name=ITCI) (Small molecular drugs manufacturer) reported for 2024 q1
(2024-05-07, Before Market Open):

- Revenue +52.6% YoY (vs +50.0% in previous quarter and historical rate +139.9%)
- EBITDA margin -13.8% increased compared to -49.5% same period last year
- Net Debt increased by $8.0 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) +$0.1 bln (positive), 1.1% of market cap
- EV/Sales multiple is 12.8x

At the opening of the session the share price went down -2.5% vs S&P500 +0.1%

------------------------------------------------

2024-05-07

#reports #GOLF

[Acushnet](https://eninvs.com/all.php?name=GOLF) (Golf products supplier) reported for 2024 q1
(2024-05-07, Before Market Open):

- Revenue +3.2% YoY (vs -7.6% in previous quarter and historical rate +13.3%)
- EBITDA -2.9% YoY (vs -163.6% in previous quarter and historical rate +8.9%)
- EBITDA margin 18.9% decreased compared to 20.1% same period last year
- Net Debt increased by $177.0 mln over the past reporting period (4.3% of market cap)
- FCF (LTM) +$0.1 bln (positive), 3.3% of market cap
- EV/EBITDA multiple is 16.2x compared to historical level (75th percentile) of 14.2x
- EV/Sales multiple is 2.1x

At the opening of the session the share price went up +4.1% vs S&P500 +0.1%

------------------------------------------------

2024-05-07

#reports #FWRG

[First Watch Restaurant Group, Inc.](https://eninvs.com/all.php?name=FWRG) (Restaurants) reported for [2024 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=167907)
(2024-05-07, Before Market Open):

- Revenue +14.7% YoY (vs +31.7% in previous quarter and historical rate +33.7%)
- EBITDA +4.2% YoY (vs -1200.0% in previous quarter and historical rate +29.2%)
- EBITDA margin 10.3% decreased compared to 11.4% same period last year
- EV/EBITDA multiple is 34.4x compared to historical level (75th percentile) of 59.9x
- EV/Sales multiple is 2.2x

At the opening of the session the share price went down -12.7% vs S&P500 +0.1%

------------------------------------------------

2024-05-07

#reports #ESPR

[Esperion Therapeutics](https://eninvs.com/all.php?name=ESPR) (Medical device manufacturer) reported for 2024 q1
(2024-05-07, Before Market Open):

- Revenue +475.0% YoY (vs +68.4% in previous quarter and historical rate +60.5%)
- EBITDA margin 52.2% increased compared to -204.2% same period last year
- EV/Sales multiple is 1.6x

At the opening of the session the share price went up +14.6% vs S&P500 +0.1%

------------------------------------------------

2024-05-07

#reports #EHTH

[eHealth](https://eninvs.com/all.php?name=EHTH) (Insurance services provider) reported for 2024 q1
(2024-05-07, Before Market Open):

- Revenue +25.7% YoY (vs +26.5% in previous quarter and historical rate -5.6%)
- Net Income margin -18.3% increased compared to -27.0% same period last year
- P/S multiple is 0.3x
- Price to book: 0.2x

At the opening of the session the share price went up +6.9% vs S&P500 +0.1%

------------------------------------------------

2024-05-07

#reports #DORM

[Dorman Products](https://eninvs.com/all.php?name=DORM) ( Automotive products supplier ) reported for [2024 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=167921)
(2024-05-07, Before Market Open):

- Revenue +0.4% YoY (vs +285.2% in previous quarter and historical rate +37.5%)
- EBITDA +112.5% YoY (vs +484.8% in previous quarter and historical rate +36.0%)
- EBITDA margin 14.5% increased compared to 6.9% same period last year
- Net Debt decreased by $10.0 mln over the past reporting period (0.3% of market cap)
- FCF (LTM) +$0.2 bln (positive), 5.2% of market cap
- EV/EBITDA multiple is 7.5x compared to historical level (75th percentile) of 16.5x
- EV/Sales multiple is 1.1x

At the opening of the session the share price went up +2.5% vs S&P500 +0.1%

------------------------------------------------

2024-05-07

#reports #DKL

[Delek Logistics Partners](https://eninvs.com/all.php?name=DKL) (Oil and Gas Midstream) reported for 2024 q1
(2024-05-07, Before Market Open):

- Revenue +3.3% YoY (vs -5.6% in previous quarter and historical rate +25.4%)
- EBITDA +7.1% YoY (vs -7.4% in previous quarter and historical rate +10.4%)
- EBITDA margin 35.7% increased compared to 34.4% same period last year
- Net Debt decreased by $103.0 mln over the past reporting period (6.0% of market cap)
- FCF (LTM) +$0.1 bln (positive), 6.8% of market cap
- EV/EBITDA multiple is 9.8x compared to historical level (75th percentile) of 12.7x
- EV/Sales multiple is 3.2x

At the opening of the session the share price went down -1.6% vs S&P500 +0.1%

------------------------------------------------

2024-05-07

#reports #CMT

[Core Molding Technologies](https://eninvs.com/all.php?name=CMT) (Specialty Chemicals) reported for 2024 q1
(2024-05-07, Before Market Open):

- Revenue -22.0% YoY (vs -14.0% in previous quarter and historical rate +18.0%)
- EBITDA -27.3% YoY (vs +20.0% in previous quarter and historical rate +43.4%)
- EBITDA margin 10.3% decreased compared to 11.0% same period last year
- EV/EBITDA multiple is 4.6x compared to historical level (75th percentile) of 6.3x
- EV/Sales multiple is 0.5x

At the opening of the session the share price went down -2.6% vs S&P500 +0.1%

------------------------------------------------

2024-05-07

#reports #CELH

[Celsius](https://eninvs.com/all.php?name=CELH) (Food products provider) reported for 2024 q1
(2024-05-07, Before Market Open):

- Revenue +36.9% YoY (vs +94.9% in previous quarter and historical rate +114.8%)
- EBITDA +77.6% YoY (vs +5900.0% in previous quarter and historical rate +98.1%)
- EBITDA margin 24.4% increased compared to 18.8% same period last year
- Net Debt decreased by $123.0 mln over the past reporting period (2.0% of market cap)
- FCF (LTM) +$0.2 bln (positive), 2.6% of market cap
- EV/EBITDA multiple is 18.4x compared to historical level (75th percentile) of 466.3x
- EV/Sales multiple is 4.2x

At the opening of the session the share price went down -3.3% vs S&P500 +0.1%

------------------------------------------------

2024-05-07

#reports #BVS

[Bioventus Inc.](https://eninvs.com/all.php?name=BVS) (Medical Devices) reported for 2024 q1
(2024-05-07, Before Market Open):

- Revenue +8.4% YoY (vs +7.1% in previous quarter and historical rate +0.1%)
- EBITDA margin 35.7% increased compared to -63.9% same period last year
- Net Debt increased by $7.0 mln over the past reporting period (2.8% of market cap)
- FCF (LTM) +$0.0 bln (positive), 17.9% of market cap
- EV/EBITDA multiple is 4.5x compared to historical level (75th percentile) of 39.6x
- EV/Sales multiple is 1.3x

At the opening of the session the share price went up +23.8% vs S&P500 +0.1%

------------------------------------------------

2024-05-07

#reports #BLMN

[Bloomin Brands](https://eninvs.com/all.php?name=BLMN) (Restaurants owner) reported for 2024 q1
(2024-05-07, Before Market Open):

- Revenue -4.0% YoY (vs +9.0% in previous quarter and historical rate +16.2%)
- EBITDA -24.6% YoY (vs -68.4% in previous quarter and historical rate +26.6%)
- EBITDA margin 10.5% decreased compared to 13.4% same period last year
- Net Debt decreased by $20.0 mln over the past reporting period (0.9% of market cap)
- FCF (LTM) +$0.0 bln (positive), 0.8% of market cap
- EV/EBITDA multiple is 4.2x compared to historical level (75th percentile) of 5.0x
- EV/Sales multiple is 0.4x

At the opening of the session the share price went down -3.0% vs S&P500 +0.1%

------------------------------------------------

2024-05-07

#reports #BLD

[TopBuild](https://eninvs.com/all.php?name=BLD) (Building products provider) reported for 2024 q1
(2024-05-07, Before Market Open):

- Revenue +1.1% YoY (vs +1.7% in previous quarter and historical rate +24.8%)
- EBITDA +7.3% YoY (vs +2.6% in previous quarter and historical rate +42.9%)
- EBITDA margin 19.5% increased compared to 18.3% same period last year
- Net Debt decreased by $135.0 mln over the past reporting period (1.0% of market cap)
- FCF (LTM) +$0.7 bln (positive), 5.2% of market cap
- EV/EBITDA multiple is 13.2x compared to historical level (75th percentile) of 15.7x
- EV/Sales multiple is 2.7x

At the opening of the session the share price went down -2.4% vs S&P500 +0.1%

------------------------------------------------

2024-05-07

#reports #AVNT

[Avient Corporation](https://eninvs.com/all.php?name=AVNT) (Polymer materials manufacturer ) reported for 2024 q1
(2024-05-07, Before Market Open):

- Revenue -2.0% YoY (vs -9.0% in previous quarter and historical rate +1.2%)
- EBITDA +34.3% YoY (vs +3.6% in previous quarter and historical rate +9.2%)
- EBITDA margin 17.5% increased compared to 12.8% same period last year
- Net Debt increased by $1.7 bln over the past reporting period (40.4% of market cap)
- FCF (LTM) -$0.0 bln (negative), 1.1% of market cap
- EV/EBITDA multiple is 14.0x compared to historical level (75th percentile) of 13.3x
- EV/Sales multiple is 1.8x

At the opening of the session the share price went up +5.0% vs S&P500 +0.1%

------------------------------------------------

2024-05-07

#reports #AUDC

[AudioCodes](https://eninvs.com/all.php?name=AUDC) (Communication Equipment) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=AUDC&q=2024 q1&id=778790)
(2024-05-07, Before Market Open):

- Revenue +1.7% YoY (vs -9.9% in previous quarter and historical rate +3.0%)
- EBITDA margin 5.0% increased compared to -1.7% same period last year
- Net Debt decreased by $9.0 mln over the past reporting period (2.4% of market cap)
- FCF (LTM) -$0.0 bln (negative), 3.8% of market cap
- EV/EBITDA multiple is 14.9x compared to historical level (75th percentile) of 21.5x
- EV/Sales multiple is 1.5x

At the opening of the session the share price went down -13.1% vs S&P500 +0.1%

------------------------------------------------

2024-05-07

#reports #ATKR

[Atkore](https://eninvs.com/all.php?name=ATKR) (Cable ducts for electrical wiring manufacturer ) reported for [2024 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=167896)
(2024-02-01, Before Market Open):

- Revenue -11.5% YoY (vs -4.3% in previous quarter and historical rate +26.3%)
- EBITDA -22.4% YoY (vs -20.9% in previous quarter and historical rate +42.2%)
- EBITDA margin 26.2% decreased compared to 29.9% same period last year
- Net Debt increased by $782.0 mln over the past reporting period (10.8% of market cap)
- FCF (LTM) +$0.8 bln (positive), 11.5% of market cap
- EV/EBITDA multiple is 7.8x compared to historical level (75th percentile) of 6.6x
- EV/Sales multiple is 2.3x

The company showed EPS +$3.67 per share. At the opening of the session the share price went down -3.0% vs S&P500 +0.2%

------------------------------------------------

2024-05-07

#reports #ARVN

[Arvinas](https://eninvs.com/all.php?name=ARVN) (Cancer drug developer) reported for 2024 q1
(2024-05-02, Before Market Open):

- Revenue -21.9% YoY (vs -100.0% in previous quarter and historical rate +71.7%)
- EBITDA margin -328.0% decreased compared to -268.8% same period last year
- Net Debt increased by $1.3 bln over the past reporting period (74.1% of market cap)
- EV/Sales multiple is 3.9x

At the opening of the session the share price went up +2.0% vs S&P500 +0.6%

------------------------------------------------

2024-05-07

#reports #ARMK

[Aramark](https://eninvs.com/all.php?name=ARMK) (Catering, Facility and Human Resources Service provider) reported for 2024 q1
(2024-05-07, Before Market Open):

- Revenue -54.4% YoY (vs -4.2% in previous quarter and historical rate +52.4%)
- EBITDA -16.0% YoY (vs -19.0% in previous quarter and historical rate +76.7%)
- EBITDA margin 6.4% increased compared to 3.5% same period last year
- Net Debt decreased by $115.0 mln over the past reporting period (1.4% of market cap)
- FCF (LTM) +$2.1 bln (positive), 25.9% of market cap
- EV/EBITDA multiple is 10.8x compared to historical level (75th percentile) of 20.1x
- EV/Sales multiple is 0.3x

At the opening of the session the share price went down -2.2% vs S&P500 +0.1%

------------------------------------------------

2024-05-07

#reports #APLS

[Apellis Pharmaceuticals](https://eninvs.com/all.php?name=APLS) (Therapeutic drug developer) reported for [2024 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=167905)
(2024-05-07, Before Market Open):

- Revenue +282.2% YoY (vs +534.8% in previous quarter and historical rate +153.7%)
- EBITDA margin -36.0% increased compared to -388.9% same period last year
- Net Debt decreased by $42.0 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) -$0.1 bln (negative), 2.0% of market cap
- EV/Sales multiple is 9.4x

At the opening of the session the share price went down -9.9% vs S&P500 +0.1%

------------------------------------------------

2024-05-07

#reports #AOMR

[Angel Oak Mortgage, Inc.](https://eninvs.com/all.php?name=AOMR) (REIT — Mortgage) reported for 2024 q1
(2024-05-07, Before Market Open):

- Revenue +28.6% YoY (vs +14.3% in previous quarter and historical rate +32.6%)
- EBITDA margin -455.6% increased compared to -628.6% same period last year
- Net Debt decreased by $5.0 mln over the past reporting period (1.8% of market cap)
- FCF (LTM) +$0.2 bln (positive), 54.5% of market cap
- EV/Sales multiple is 17.6x

At the opening of the session the share price went up +0.1% vs S&P500 +0.1%

------------------------------------------------

2024-05-07

#reports #AHCO

[AdaptHealth](https://eninvs.com/all.php?name=AHCO) (Medical Devices) reported for 2024 q1
(2024-05-07, Before Market Open):

- Revenue +6.3% YoY (vs +10.0% in previous quarter and historical rate +43.8%)
- EBITDA +19.2% YoY (vs -196.9% in previous quarter and historical rate +23.4%)
- EBITDA margin 18.1% increased compared to 16.1% same period last year
- Net Debt increased by $55.0 mln over the past reporting period (3.9% of market cap)
- FCF (LTM) -$0.0 bln (negative), 1.3% of market cap
- EV/Sales multiple is 1.1x

At the opening of the session the share price went down -5.9% vs S&P500 +0.1%

------------------------------------------------

2024-05-07

#reports #DDOG
@ cloud-computing , @ saas

[Datadog](https://eninvs.com/all.php?name=DDOG) (Software provider) reported for 2024 q1
(2024-05-07, Before Market Open):

- Revenue +26.8% YoY (vs +25.8% in previous quarter and historical rate +51.9%)
- EBITDA margin 6.2% increased compared to -4.6% same period last year
- Net Debt decreased by $143.0 mln over the past reporting period (0.3% of market cap)
- FCF (LTM) +$2.0 bln (positive), 4.7% of market cap
- EV/EBITDA multiple is 334.9x compared to historical level (75th percentile) of 2265.4x
- EV/Sales multiple is 17.7x

At the opening of the session the share price went down -9.8% vs S&P500 +0.1%

------------------------------------------------

2024-05-07

#reports #ZETA

[Zeta Global Holdings Corp.](https://eninvs.com/all.php?name=ZETA) (Software — Application) reported for 2024 q1
(2024-05-06, After Market Close):

- Revenue +23.4% YoY (vs +20.0% in previous quarter and historical rate +26.1%)
- EBITDA margin -11.3% increased compared to -25.9% same period last year
- Net Debt decreased by $9.0 mln over the past reporting period (0.4% of market cap)
- FCF (LTM) +$0.0 bln (positive), 1.5% of market cap
- EV/Sales multiple is 3.0x

The company showed EPS -$0.23 per share

------------------------------------------------

2024-05-07

#reports #WMB

[Williams](https://eninvs.com/all.php?name=WMB) (Energy company) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=WMB&q=2024 q1&id=777482)
(2024-05-06, After Market Close):

- Revenue +8.0% YoY (vs -37.5% in previous quarter and historical rate +9.4%)
- EBITDA +15.4% YoY (vs +20.2% in previous quarter and historical rate +12.9%)
- EBITDA margin 56.4% increased compared to 52.8% same period last year
- Net Debt increased by $2.0 bln over the past reporting period (4.1% of market cap)
- FCF (LTM) -$2.2 bln (negative), 4.6% of market cap
- EV/EBITDA multiple is 13.5x compared to historical level (75th percentile) of 14.2x
- EV/Sales multiple is 7.5x

The company showed EPS +$0.52 per share

------------------------------------------------

2024-05-07

#reports #VRTX

[Vertex Pharmaceuticals](https://eninvs.com/all.php?name=VRTX) (Pharmaceutical developer) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=VRTX&q=2024 q1&id=777481)
(2024-05-06, After Market Close):

- Revenue +13.3% YoY (vs +9.3% in previous quarter and historical rate +16.9%)
- EBITDA +46.3% YoY (vs -4.2% in previous quarter and historical rate +17.1%)
- EBITDA margin 40.0% increased compared to 31.0% same period last year
- Net Debt increased by $1.0 bln over the past reporting period (1.0% of market cap)
- FCF (LTM) -$0.2 bln (negative), 0.2% of market cap
- EV/EBITDA multiple is 22.6x compared to historical level (75th percentile) of 21.3x
- EV/Sales multiple is 9.2x

------------------------------------------------

2024-05-07

#reports #VRNS

[Varonis Systems](https://eninvs.com/all.php?name=VRNS) (Software developer) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=VRNS&q=2024 q1&id=777480)
(2024-05-06, After Market Close):

- Revenue +6.5% YoY (vs +249.0% in previous quarter and historical rate +33.8%)
- EBITDA margin -32.5% increased compared to -34.6% same period last year
- Net Debt decreased by $17.0 mln over the past reporting period (0.4% of market cap)
- FCF (LTM) -$0.2 bln (negative), 3.8% of market cap
- EV/Sales multiple is 4.7x

------------------------------------------------

2024-05-07

#reports #VAC

[Marriott Vacations Worldwide Corporation](https://eninvs.com/all.php?name=VAC) (Vacation services provider) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=VAC&q=2024 q1&id=777477)
(2024-05-06, After Market Close):

- Revenue +2.2% YoY (vs +0.5% in previous quarter and historical rate +25.6%)
- EBITDA +2.9% YoY (vs -63.9% in previous quarter and historical rate +113.5%)
- EBITDA margin 61.4% increased compared to 61.0% same period last year
- EV/EBITDA multiple is 1.6x compared to historical level (75th percentile) of 25.8x
- EV/Sales multiple is 1.0x

On post-market the stock shows a decrease by -0.2%

------------------------------------------------

2024-05-07

#reports #TVTX

[Travere Therapeutics](https://eninvs.com/all.php?name=TVTX) (Biotechnology) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=TVTX&q=2024 q1&id=777475)
(2024-05-06, After Market Close):

- Revenue -28.1% YoY (vs -19.6% in previous quarter and historical rate -1.0%)
- EBITDA margin -314.6% decreased compared to -152.6% same period last year
- Net Debt increased by $14.0 mln over the past reporting period (2.8% of market cap)
- FCF (LTM) -$0.1 bln (negative), 22.6% of market cap
- EV/Sales multiple is 2.7x

The company showed EPS -$1.76 per share

------------------------------------------------

2024-05-07

#reports #TTOO

[T2 Biosystems](https://eninvs.com/all.php?name=TTOO) (Diagnostics and Research) reported for [2024 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=167877)
(2023-03-01, After Market Close):

- Revenue 0.0% YoY (vs 0.0% in previous quarter and historical rate -1.5%)
- EBITDA margin -325.0% has not changed compared to -325.0% same period last year
- Net Debt increased by $10.0 mln over the past reporting period (3.4% of market cap)
- FCF (LTM) +$0.0 bln (positive), 4.8% of market cap
- EV/Sales multiple is 21.5x

The company showed EPS -$0.00 per share. At the opening of the session the share price went up +0.8% vs S&P500 -0.4%

------------------------------------------------

2024-05-07

#reports #TRUE

[TrueCar](https://eninvs.com/all.php?name=TRUE) (Internet Content and Information) reported for [2024 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=167889)
(2024-04-30, After Market Close):

- Revenue +10.8% YoY (vs +10.8% in previous quarter and historical rate -13.8%)
- EBITDA margin -7.3% increased compared to -45.9% same period last year
- EV/Sales multiple is 1.7x

The company showed EPS -$0.06 per share. At the opening of the session the share price went up +0.8% vs S&P500 -0.1%

------------------------------------------------

2024-05-07

#reports #TDUP

[ThredUp Inc.](https://eninvs.com/all.php?name=TDUP) (Internet Retail) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=TDUP&q=2024 q1&id=777474)
(2024-05-06, After Market Close):

- Revenue +5.3% YoY (vs +14.1% in previous quarter and historical rate +35.4%)
- EBITDA margin -15.0% increased compared to -22.4% same period last year
- Net Debt increased by $6.0 mln over the past reporting period (3.2% of market cap)
- FCF (LTM) -$0.0 bln (negative), 15.6% of market cap
- EV/Sales multiple is 0.6x

The company showed EPS -$0.15 per share

------------------------------------------------

2024-05-07

#reports #TCMD

[Tactile Systems Technology](https://eninvs.com/all.php?name=TCMD) (Medical device manufacturer) reported for [2024 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=167752)
(2024-05-06, After Market Close):

- Revenue +3.4% YoY (vs +5.4% in previous quarter and historical rate +15.3%)
- EBITDA margin -1.6% increased compared to -3.4% same period last year
- Net Debt decreased by $1.0 mln over the past reporting period (0.3% of market cap)
- FCF (LTM) +$0.0 bln (positive), 9.3% of market cap
- EV/EBITDA multiple is 11.2x compared to historical level (75th percentile) of 207.5x
- EV/Sales multiple is 1.0x

------------------------------------------------

2024-05-07

#reports #TBI

[TrueBlue](https://eninvs.com/all.php?name=TBI) (Staffing and Employment Services) reported for [2024 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=167751)
(2024-05-06, After Market Close):

- Revenue -13.3% YoY (vs -11.8% in previous quarter and historical rate +2.5%)
- EBITDA margin -4.0% decreased compared to -1.3% same period last year
- Net Debt increased by $27.0 mln over the past reporting period (8.2% of market cap)
- FCF (LTM) -$0.1 bln (negative), 21.6% of market cap
- EV/Sales multiple is 0.2x

The company showed EPS -$0.05 per share

------------------------------------------------

2024-05-07

#reports #SWAV

[Shockwave Medical](https://eninvs.com/all.php?name=SWAV) (Medical device manufacturer) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=SWAV&q=2024 q1&id=777470)
(2024-05-06, After Market Close):

- Revenue +36.0% YoY (vs +41.0% in previous quarter and historical rate +110.2%)
- EBITDA +7.3% YoY (vs +2.1% in previous quarter and historical rate +127.2%)
- EBITDA margin 20.1% decreased compared to 25.5% same period last year
- Net Debt decreased by $32.0 mln over the past reporting period (0.3% of market cap)
- FCF (LTM) -$0.0 bln (negative), 0.2% of market cap
- EV/EBITDA multiple is 62.4x compared to historical level (75th percentile) of 136.6x
- EV/Sales multiple is 13.5x

The company showed EPS +$1.44 per share

------------------------------------------------

2024-05-07

#reports #SIBN

[SI-BONE](https://eninvs.com/all.php?name=SIBN) (Medical device manufacturer) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=SIBN&q=2024 q1&id=777468)
(2024-05-06, After Market Close):

- Revenue +15.2% YoY (vs +21.9% in previous quarter and historical rate +25.0%)
- EBITDA margin -28.9% increased compared to -30.3% same period last year
- Net Debt increased by $8.0 mln over the past reporting period (1.6% of market cap)
- FCF (LTM) +$0.1 bln (positive), 14.7% of market cap
- EV/Sales multiple is 2.6x

At the opening of the session the share price went down -98.0%

------------------------------------------------

2024-05-07

#reports #SEMR

[Semrush Holdings, Inc.](https://eninvs.com/all.php?name=SEMR) (Software — Application) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=SEMR&q=2024 q1&id=777467)
(2024-05-06, After Market Close):

- Revenue +21.1% YoY (vs +20.3% in previous quarter and historical rate +30.0%)
- EBITDA margin 7.0% increased compared to -12.7% same period last year
- Net Debt decreased by $6.0 mln over the past reporting period (0.3% of market cap)
- FCF (LTM) +$0.0 bln (positive), 0.2% of market cap
- EV/EBITDA multiple is 87.8x compared to historical level (75th percentile) of 1205.0x
- EV/Sales multiple is 5.2x

------------------------------------------------

2024-05-07

#reports #RXST

[RxSight, Inc.](https://eninvs.com/all.php?name=RXST) (Medical Devices) reported for [2024 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=167749)
(2024-05-06, After Market Close):

- Revenue +76.5% YoY (vs +81.3% in previous quarter and historical rate +89.1%)
- EBITDA margin -33.3% increased compared to -70.6% same period last year
- Net Debt increased by $1.0 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) +$0.0 bln (positive), 0.8% of market cap
- EV/Sales multiple is 15.8x

The company showed EPS -$0.25 per share

------------------------------------------------

2024-05-07

#reports #PRAA

[PRA](https://eninvs.com/all.php?name=PRAA) (Financial services provider) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=PRAA&q=2024 q1&id=777462)
(2024-05-06, After Market Close):

- Revenue +65.2% YoY (vs -0.9% in previous quarter and historical rate -4.3%)
- Net Income margin 4.7% increased compared to -34.8% same period last year
- P/E multiple is 22.6x compared to historical level (75th percentile) of 21.4x
- P/S multiple is 1.1x
- Price to book: 0.9x

------------------------------------------------

2024-05-07

#reports #PLYA

[Playa Hotels & Resorts NV](https://eninvs.com/all.php?name=PLYA) (Resorts and Casinos) reported for [2024 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=167747)
(2024-05-06, After Market Close):

- Revenue +9.9% YoY (vs +15.2% in previous quarter and historical rate +78.5%)
- EBITDA +13.5% YoY (vs +17.0% in previous quarter and historical rate +92.9%)
- EBITDA margin 36.2% increased compared to 35.0% same period last year
- EV/EBITDA multiple is 7.7x compared to historical level (75th percentile) of 10.6x
- EV/Sales multiple is 2.1x

The company showed EPS +$0.40 per share

------------------------------------------------

2024-05-07

#reports #PLTR

[Palantir Technologies](https://eninvs.com/all.php?name=PLTR) (Software provider) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=PLTR&q=2024 q1&id=777460)
(2024-05-06, After Market Close):

- Revenue +20.8% YoY (vs +19.4% in previous quarter and historical rate +25.2%)
- EBITDA +641.7% YoY (vs +7300.0% in previous quarter and historical rate +83.3%)
- EBITDA margin 14.0% increased compared to 2.3% same period last year
- Net Debt decreased by $206.0 mln over the past reporting period (0.4% of market cap)
- FCF (LTM) +$1.0 bln (positive), 1.9% of market cap
- EV/EBITDA multiple is 210.7x compared to historical level (75th percentile) of 483.1x
- EV/Sales multiple is 20.8x

------------------------------------------------

2024-05-07

#reports #PLCE

[Childrens Place](https://eninvs.com/all.php?name=PLCE) (Clothes seller) reported for [2023 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=167868)
(2024-05-16, Before Market Open):

- Revenue +251.5% YoY (vs -5.7% in previous quarter and historical rate +21.0%)
- EBITDA margin -4.5% decreased compared to -3.3% same period last year
- Net Debt decreased by $538.0 mln over the past reporting period (533.9% of market cap)
- FCF (LTM) -$0.0 bln (negative), 42.7% of market cap
- EV/Sales multiple is 0.2x

------------------------------------------------

2024-05-07

#reports #PAY

[Paymentus Holdings, Inc.](https://eninvs.com/all.php?name=PAY) (Information Technology Services) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=PAY&q=2024 q1&id=777459)
(2024-05-06, After Market Close):

- Revenue +25.0% YoY (vs +25.0% in previous quarter and historical rate +25.5%)
- EBITDA +183.3% YoY (vs +112.5% in previous quarter and historical rate +65.2%)
- EBITDA margin 9.2% increased compared to 4.1% same period last year
- Net Debt decreased by $1.0 mln over the past reporting period (0.0% of market cap)
- FCF (LTM) +$0.0 bln (positive), 1.4% of market cap
- EV/EBITDA multiple is 43.8x compared to historical level (75th percentile) of 70.4x
- EV/Sales multiple is 4.0x

The company showed EPS +$0.06 per share

------------------------------------------------

2024-05-07

#reports #OSTK

[Overstock](https://eninvs.com/all.php?name=OSTK) (Online-retailer) reported for 2024 q1
(2023-10-26, Before Market Open):

- Revenue +0.3% YoY (vs -5.2% in previous quarter and historical rate -17.3%)
- EBITDA margin -14.1% decreased compared to -0.5% same period last year
- Net Debt increased by $45.0 mln over the past reporting period (5.9% of market cap)
- FCF (LTM) -$0.1 bln (negative), 15.1% of market cap
- EV/Sales multiple is 0.3x

At the opening of the session the share price went down -1.0% vs S&P500 -0.3%

------------------------------------------------

2024-05-07

#reports #OGS

[ONE Gas](https://eninvs.com/all.php?name=OGS) (Gas provider) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=OGS&q=2024 q1&id=777457)
(2024-05-06, After Market Close):

- Revenue -26.6% YoY (vs -25.9% in previous quarter and historical rate +12.5%)
- EBITDA +0.9% YoY (vs +9.1% in previous quarter and historical rate +17.3%)
- EBITDA margin 29.3% increased compared to 21.3% same period last year
- Net Debt increased by $115.0 mln over the past reporting period (3.1% of market cap)
- FCF (LTM) -$0.9 bln (negative), 24.0% of market cap
- EV/EBITDA multiple is 21.3x compared to historical level (75th percentile) of 24.8x
- EV/Sales multiple is 6.7x

------------------------------------------------

2024-05-07

#reports #NINE

[Nine Energy Service](https://eninvs.com/all.php?name=NINE) (Oil and Gas Equipment and Services) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=NINE&q=2024 q1&id=778247)
(2024-05-06, After Market Close):

- Revenue -12.9% YoY (vs -13.8% in previous quarter and historical rate +42.2%)
- EBITDA -15.0% YoY (vs -48.3% in previous quarter and historical rate +96.1%)
- EBITDA margin 12.0% decreased compared to 12.3% same period last year
- Net Debt increased by $15.0 mln over the past reporting period (20.0% of market cap)
- FCF (LTM) +$0.0 bln (positive), 2.7% of market cap
- EV/EBITDA multiple is 6.3x compared to historical level (75th percentile) of 22.5x
- EV/Sales multiple is 0.7x

------------------------------------------------

2024-05-07

#reports #MCHP

[Microchip Technology](https://eninvs.com/all.php?name=MCHP) (Semiconductor products manufacturer) reported for 2024 q1
(2024-05-06, After Market Close):

- Revenue -40.6% YoY (vs -18.6% in previous quarter and historical rate +13.6%)
- EBITDA -52.8% YoY (vs -26.7% in previous quarter and historical rate +21.8%)
- EBITDA margin 40.1% decreased compared to 50.4% same period last year
- Net Debt increased by $266.0 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) +$0.9 bln (positive), 1.7% of market cap
- EV/EBITDA multiple is 16.3x compared to historical level (75th percentile) of 16.9x
- EV/Sales multiple is 7.6x

------------------------------------------------

2024-05-07

#reports #KVHI

[KVH Industries](https://eninvs.com/all.php?name=KVHI) (Communication Equipment) reported for [2024 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=167768)
(2024-05-06, Before Market Open):

- Revenue -14.7% YoY (vs -13.9% in previous quarter and historical rate -6.2%)
- EBITDA -133.3% YoY (vs -1300.0% in previous quarter)
- EBITDA margin -3.4% decreased compared to 8.8% same period last year
- Net Debt increased by $4.0 mln over the past reporting period (4.1% of market cap)
- FCF (LTM) -$0.0 bln (negative), 2.1% of market cap
- EV/EBITDA multiple is 10.5x compared to historical level (75th percentile) of 15.5x
- EV/Sales multiple is 0.2x

At the opening of the session the share price went up +0.2% vs S&P500 +0.3%

------------------------------------------------

2024-05-07

#reports #KIDS

[OrthoPediatrics](https://eninvs.com/all.php?name=KIDS) (Medical equipment developer) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=KIDS&q=2024 q1&id=777447)
(2024-05-06, After Market Close):

- Revenue +40.6% YoY (vs +22.6% in previous quarter and historical rate +31.0%)
- EBITDA margin -13.3% increased compared to -15.6% same period last year
- Net Debt increased by $33.0 mln over the past reporting period (4.3% of market cap)
- FCF (LTM) -$0.1 bln (negative), 9.2% of market cap
- EV/Sales multiple is 4.5x

------------------------------------------------

2024-05-07

#reports #INTT

[inTEST Corporation](https://eninvs.com/all.php?name=INTT) (Semiconductor Equipment and Materials) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=INTT&q=2024 q1&id=777444)
(2024-05-06, After Market Close):

- Revenue -6.3% YoY (vs -12.5% in previous quarter and historical rate +28.9%)
- EBITDA -60.0% YoY (vs -60.0% in previous quarter)
- EBITDA margin 6.7% decreased compared to 15.6% same period last year
- Net Debt increased by $36.0 mln over the past reporting period (25.6% of market cap)
- FCF (LTM) -$0.0 bln (negative), 3.6% of market cap
- EV/EBITDA multiple is 8.0x compared to historical level (75th percentile) of 14.0x
- EV/Sales multiple is 0.8x

The company showed EPS +$0.05 per share

------------------------------------------------

2024-05-07

#reports #IFF

[International Flavors & Fragrances](https://eninvs.com/all.php?name=IFF) (Flavor manufacturer) reported for [2024 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=167767)
(2024-05-06, After Market Close):

- Revenue +10.1% YoY (vs -5.0% in previous quarter and historical rate +37.5%)
- EBITDA +17.2% YoY (vs -681.1% in previous quarter and historical rate +26.7%)
- EBITDA margin 14.3% increased compared to 13.4% same period last year
- Net Debt increased by $15.2 bln over the past reporting period (67.1% of market cap)
- FCF (LTM) +$4.6 bln (positive), 20.2% of market cap
- EV/Sales multiple is 4.0x

------------------------------------------------

2024-05-07

#reports #HSII

[Heidrick & Struggles International](https://eninvs.com/all.php?name=HSII) (Executive recruitment specialist) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=HSII&q=2024 q1&id=777441)
(2024-05-06, After Market Close):

- Revenue +11.2% YoY (vs +7.5% in previous quarter and historical rate +23.1%)
- EBITDA -4.5% YoY (vs +17.4% in previous quarter and historical rate +28.4%)
- EBITDA margin 7.8% decreased compared to 9.1% same period last year
- Net Debt increased by $224.0 mln over the past reporting period (36.7% of market cap)
- FCF (LTM) -$0.2 bln (negative), 38.5% of market cap
- EV/EBITDA multiple is 4.9x compared to historical level (75th percentile) of 4.0x
- EV/Sales multiple is 0.4x

The company showed EPS +$0.67 per share

------------------------------------------------

2024-05-07

#reports #FN

[Fabrinet](https://eninvs.com/all.php?name=FN) (Electronic Components) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=FN&q=2024 q1&id=777437)
(2024-05-06, After Market Close):

- Revenue +10.1% YoY (vs +6.6% in previous quarter and historical rate +16.5%)
- EBITDA +15.1% YoY (vs +5.2% in previous quarter and historical rate +22.4%)
- EBITDA margin 11.5% increased compared to 11.0% same period last year
- Net Debt decreased by $59.0 mln over the past reporting period (0.9% of market cap)
- FCF (LTM) +$0.3 bln (positive), 3.9% of market cap
- EV/EBITDA multiple is 19.3x compared to historical level (75th percentile) of 18.7x
- EV/Sales multiple is 2.2x

The company showed EPS +$2.21 per share

------------------------------------------------

2024-05-07

#reports #FMC

[FMC](https://eninvs.com/all.php?name=FMC) (Agricultural chemicals supplier) reported for 2024 q1
(2024-05-06, After Market Close):

- Revenue -31.7% YoY (vs -29.3% in previous quarter and historical rate -1.7%)
- EBITDA -81.6% YoY (vs -99.5% in previous quarter and historical rate -20.0%)
- EBITDA margin 5.9% decreased compared to 21.8% same period last year
- Net Debt increased by $263.0 mln over the past reporting period (3.4% of market cap)
- FCF (LTM) -$0.2 bln (negative), 2.6% of market cap
- EV/EBITDA multiple is 47.3x compared to historical level (75th percentile) of 17.6x
- EV/Sales multiple is 2.9x

The company showed EPS +$0.08 per share

------------------------------------------------

2024-05-07

#reports #FHB

[First Hawaiian](https://eninvs.com/all.php?name=FHB) (Banks — Regional) reported for [2024 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=167807)
(2024-04-26, Before Market Open):

- Revenue -7.8% YoY (vs -11.6% in previous quarter and historical rate -5.9%)
- Net Income -19.4% YoY (vs -40.0% in previous quarter and historical rate +14.5%)
- Net Income margin 35.1% decreased compared to 40.1% same period last year
- P/E multiple is 12.7x compared to historical level (75th percentile) of 12.7x
- P/S multiple is 4.5x
- Price to book: 1.1x

The company showed EPS +$0.42 per share. At the opening of the session the share price went up +0.1% vs S&P500 +0.7%

------------------------------------------------

2024-05-07

#reports #FGEN

[FibroGen](https://eninvs.com/all.php?name=FGEN) (Pharmaceutical company) reported for [2024 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=167742)
(2024-05-06, After Market Close):

- Revenue +55.6% YoY (vs -20.6% in previous quarter and historical rate +29.5%)
- EBITDA margin -50.0% increased compared to -202.8% same period last year
- Net Debt increased by $55.0 mln over the past reporting period (50.6% of market cap)
- FCF (LTM) -$0.3 bln (negative), 241.8% of market cap
- EV/Sales multiple is 0.7x

The company showed EPS -$0.33 per share

------------------------------------------------

2024-05-07

#reports #EVER

[EverQuote](https://eninvs.com/all.php?name=EVER) (Platform for communication with auto insurers) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=EVER&q=2024 q1&id=777433)
(2024-05-06, After Market Close):

- Revenue -16.5% YoY (vs -36.4% in previous quarter and historical rate -7.4%)
- EBITDA margin 3.3% increased compared to -0.9% same period last year
- Net Debt increased by $38.0 mln over the past reporting period (5.2% of market cap)
- FCF (LTM) -$0.0 bln (negative), 0.4% of market cap
- EV/Sales multiple is 2.6x

------------------------------------------------

2024-05-07

#reports #ENTA

[Enanta Pharmaceuticals](https://eninvs.com/all.php?name=ENTA) (Small molecular drugs manufacturer) reported for 2024 q1
(2024-05-06, After Market Close):

- Revenue -5.6% YoY (vs -25.0% in previous quarter and historical rate -7.3%)
- EBITDA margin -188.2% increased compared to -216.7% same period last year
- Net Debt increased by $58.0 mln over the past reporting period (18.8% of market cap)
- FCF (LTM) +$0.1 bln (positive), 18.1% of market cap
- EV/Sales multiple is 0.8x

------------------------------------------------

2024-05-07

#reports #CVGI

[Commercial Vehicle Group](https://eninvs.com/all.php?name=CVGI) (Auto Parts) reported for [2024 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=167774)
(2024-05-06, After Market Close):

- Revenue -11.8% YoY (vs -5.1% in previous quarter and historical rate +11.2%)
- EBITDA -38.9% YoY (vs +900.0% in previous quarter and historical rate +35.9%)
- EBITDA margin 4.7% decreased compared to 6.8% same period last year
- Net Debt decreased by $136.0 mln over the past reporting period (67.8% of market cap)
- FCF (LTM) -$0.0 bln (negative), 6.0% of market cap
- EV/EBITDA multiple is 6.5x compared to historical level (75th percentile) of 10.9x
- EV/Sales multiple is 0.3x

------------------------------------------------

2024-05-07

#reports #COTY

[Coty](https://eninvs.com/all.php?name=COTY) (Cosmetics manufacturer) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=COTY&q=2024 q1&id=777427)
(2024-05-06, After Market Close):

- Revenue +7.5% YoY (vs +13.4% in previous quarter and historical rate +17.5%)
- EBITDA margin 5.6% increased compared to -10.4% same period last year
- Net Debt increased by $318.0 mln over the past reporting period (3.3% of market cap)
- FCF (LTM) +$0.4 bln (positive), 3.7% of market cap
- EV/EBITDA multiple is 20.2x compared to historical level (75th percentile) of 31.4x
- EV/Sales multiple is 2.3x

The company showed EPS +$0.01 per share

------------------------------------------------

2024-05-07

#reports #CMTG

[Claros Mortgage Trust, Inc.](https://eninvs.com/all.php?name=CMTG) (REIT — Mortgage) reported for [2024 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=167741)
(2024-05-06, After Market Close):

- Revenue -14.5% YoY (vs -9.5% in previous quarter and historical rate -2.9%)
- EBITDA -19.2% YoY (vs -81.8% in previous quarter and historical rate -24.2%)
- EBITDA margin 71.2% decreased compared to 75.4% same period last year
- EV/EBITDA multiple is 5.5x compared to historical level (75th percentile) of 5.3x
- EV/Sales multiple is 4.3x

The company showed EPS -$0.39 per share

------------------------------------------------

2024-05-07

#reports #BRBR

[BellRing Brands](https://eninvs.com/all.php?name=BRBR) (Packaged Foods) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=BRBR&q=2024 q1&id=777662)
(2024-05-06, After Market Close):

- Revenue +28.2% YoY (vs +18.5% in previous quarter and historical rate +21.8%)
- EBITDA +55.8% YoY (vs -2.5% in previous quarter and historical rate +39.9%)
- EBITDA margin 13.5% increased compared to 11.1% same period last year
- Net Debt increased by $6.0 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) +$0.2 bln (positive), 2.5% of market cap
- EV/EBITDA multiple is 28.1x compared to historical level (75th percentile) of 25.7x
- EV/Sales multiple is 4.6x

On post-market the stock shows a growth by +8.4%

------------------------------------------------

2024-05-07

#reports #AXON

[Axon Enterprise](https://eninvs.com/all.php?name=AXON) (Conducted energy weapons manufacturer ) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=AXON&q=2024 q1&id=777418)
(2024-05-06, After Market Close):

- Revenue +34.4% YoY (vs +28.6% in previous quarter and historical rate +33.6%)
- EBITDA 0.0% YoY (vs +65.5% in previous quarter and historical rate +67.6%)
- EBITDA margin 5.0% decreased compared to 6.7% same period last year
- Net Debt increased by $198.0 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) +$0.1 bln (positive), 0.3% of market cap
- EV/EBITDA multiple is 133.3x compared to historical level (75th percentile) of 110.4x
- EV/Sales multiple is 14.2x

------------------------------------------------

2024-05-07

#reports #ATSG

[Air Transport Services](https://eninvs.com/all.php?name=ATSG) (Air freight and aircraft leasing) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=ATSG&q=2024 q1&id=777415)
(2024-05-06, After Market Close):

- Revenue -3.0% YoY (vs -3.0% in previous quarter and historical rate +10.1%)
- EBITDA -6.8% YoY (vs -19.2% in previous quarter and historical rate +3.7%)
- EBITDA margin 25.3% decreased compared to 26.3% same period last year
- Net Debt decreased by $19.0 mln over the past reporting period (2.2% of market cap)
- FCF (LTM) -$0.2 bln (negative), 25.8% of market cap
- EV/EBITDA multiple is 4.9x compared to historical level (75th percentile) of 5.5x
- EV/Sales multiple is 1.3x

------------------------------------------------

2024-05-07

#reports #ASRT

[Assertio](https://eninvs.com/all.php?name=ASRT) (Drug Manufacturers — Specialty and Generic) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=ASRT&q=2024 q1&id=777414)
(2024-05-06, After Market Close):

- Revenue -23.8% YoY (vs -34.0% in previous quarter and historical rate +12.0%)
- EBITDA -90.9% YoY (vs -168.4% in previous quarter and historical rate +19.4%)
- EBITDA margin 3.1% decreased compared to 26.2% same period last year
- Net Debt decreased by $7.0 mln over the past reporting period (12.0% of market cap)
- FCF (LTM) +$0.0 bln (positive), 20.6% of market cap
- EV/Sales multiple is 0.1x

------------------------------------------------

2024-05-07

#reports #APLE

[Apple Hospitality REIT](https://eninvs.com/all.php?name=APLE) (Hotel business) reported for [2024 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=167759)
(2024-05-06, After Market Close):

- Revenue +6.1% YoY (vs +4.0% in previous quarter and historical rate +46.5%)
- EBITDA +25.5% YoY (vs +193.1% in previous quarter and historical rate +88.1%)
- EBITDA margin 35.8% increased compared to 30.2% same period last year
- Net Debt decreased by $150.0 mln over the past reporting period (4.2% of market cap)
- EV/EBITDA multiple is 8.2x compared to historical level (75th percentile) of 22.5x
- EV/Sales multiple is 2.7x

The company showed EPS +$0.22 per share

------------------------------------------------

2024-05-07

#reports #ALTO

[Alto Ingredients](https://eninvs.com/all.php?name=ALTO) (Specialty Chemicals) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=ALTO&q=2024 q1&id=777410)
(2024-05-06, After Market Close):

- Revenue -23.2% YoY (vs -16.5% in previous quarter and historical rate +18.3%)
- EBITDA margin -1.7% has not changed compared to -1.6% same period last year
- Net Debt increased by $85.0 mln over the past reporting period (59.9% of market cap)
- FCF (LTM) +$0.0 bln (positive), 3.5% of market cap
- EV/EBITDA multiple is 25.2x compared to historical level (75th percentile) of 17.4x
- EV/Sales multiple is 0.2x

The company showed EPS -$0.16 per share

------------------------------------------------

2024-05-07

#reports #ACM

[AECOM](https://eninvs.com/all.php?name=ACM) ( Infrastructure-related products provider) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=ACM&q=2024 q1&id=777406)
(2024-05-06, After Market Close):

- Revenue +13.0% YoY (vs +15.3% in previous quarter and historical rate +5.1%)
- EBITDA +1.3% YoY (vs +402.4% in previous quarter and historical rate +19.6%)
- EBITDA margin 6.0% decreased compared to 6.6% same period last year
- Net Debt decreased by $3.1 bln over the past reporting period (23.7% of market cap)
- FCF (LTM) +$0.2 bln (positive), 1.6% of market cap
- EV/EBITDA multiple is 23.2x compared to historical level (75th percentile) of 31.1x
- EV/Sales multiple is 0.8x

------------------------------------------------

2024-05-07

#reports #O
@ REITs

[Realtyome](https://eninvs.com/all.php?name=O) (Real estate investment trust) reported for 2024 q1
(2024-05-06, After Market Close):

- Revenue +33.5% YoY (vs +21.0% in previous quarter and historical rate +39.6%)
- EBITDA +33.1% YoY (vs +20.4% in previous quarter and historical rate +95.3%)
- EBITDA margin 100.0% decreased compared to 100.3% same period last year
- Net Debt increased by $9.3 bln over the past reporting period (25.4% of market cap)
- FCF (LTM) -$8.6 bln (negative), 23.5% of market cap
- EV/EBITDA multiple is 14.4x compared to historical level (75th percentile) of 100.5x
- EV/Sales multiple is 14.4x

The company showed EPS +$0.16 per share

------------------------------------------------

2024-05-07

#reports #FIS
@ finance-and-technology

[Fidelity National Information](https://eninvs.com/all.php?name=FIS) (Banking service provider) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=FIS&q=2024 q1&id=777435)
(2024-05-06, After Market Close):

- Revenue -29.7% YoY (vs -32.4% in previous quarter and historical rate -2.9%)
- EBITDA -36.0% YoY (vs +76000.0% in previous quarter and historical rate -12.9%)
- EBITDA margin 32.0% decreased compared to 35.1% same period last year
- Net Debt decreased by $10.8 bln over the past reporting period (25.2% of market cap)
- FCF (LTM) +$10.5 bln (positive), 24.4% of market cap
- EV/Sales multiple is 4.5x

The company showed EPS +$0.18 per share

------------------------------------------------

2024-05-06

#reports #SHO

[Sunstone Hotel Investors](https://eninvs.com/all.php?name=SHO) (REIT — Hotel and Motel) reported for 2024 q1
(2024-05-06, Before Market Open):

- Revenue -10.7% YoY (vs -10.2% in previous quarter and historical rate +86.1%)
- EBITDA -19.3% YoY (vs -69.8% in previous quarter and historical rate +103.6%)
- EBITDA margin 21.2% decreased compared to 23.5% same period last year
- Net Debt decreased by $686.0 mln over the past reporting period (33.1% of market cap)
- FCF (LTM) +$0.3 bln (positive), 15.1% of market cap
- EV/EBITDA multiple is 11.9x compared to historical level (75th percentile) of 12.1x
- EV/Sales multiple is 2.9x

At the opening of the session the share price went up +1.7% vs S&P500 +0.3%

------------------------------------------------

2024-05-06

#reports #PRFT

[Perficient](https://eninvs.com/all.php?name=PRFT) (Digital consultancy service provider) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=PRFT&q=2024 q1&id=776186)
(2024-05-06, Before Market Open):

- Revenue -6.9% YoY (vs -5.2% in previous quarter and historical rate +12.7%)
- EBITDA -53.8% YoY (vs -22.2% in previous quarter and historical rate +10.9%)
- EBITDA margin 8.4% decreased compared to 16.9% same period last year
- Net Debt increased by $13.0 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) +$0.1 bln (positive), 4.7% of market cap
- EV/EBITDA multiple is 22.3x compared to historical level (75th percentile) of 25.5x
- EV/Sales multiple is 2.2x

At the opening of the session the share price went up +53.3% vs S&P500 +0.3%

------------------------------------------------

2024-05-06

#reports #NWN

[Northwest Natural Company](https://eninvs.com/all.php?name=NWN) (Utilities — Regulated Gas) reported for 2024 q1
(2024-05-06, Before Market Open):

- Revenue -6.3% YoY (vs -5.1% in previous quarter and historical rate +15.0%)
- EBITDA -2.1% YoY (vs -3.5% in previous quarter and historical rate +6.5%)
- EBITDA margin 33.0% increased compared to 31.6% same period last year
- Net Debt decreased by $93.0 mln over the past reporting period (7.9% of market cap)
- FCF (LTM) -$0.1 bln (negative), 11.3% of market cap
- EV/EBITDA multiple is 9.3x compared to historical level (75th percentile) of 11.6x
- EV/Sales multiple is 2.5x

At the opening of the session the share price went down -2.4% vs S&P500 +0.3%

------------------------------------------------

2024-05-06

#reports #MODN

[Model N](https://eninvs.com/all.php?name=MODN) (Software developer) reported for 2024 q1
(2024-05-06, Before Market Open):

- Revenue +3.2% YoY (vs +6.8% in previous quarter and historical rate +14.2%)
- EBITDA margin -1.5% has not changed compared to -1.6% same period last year
- Net Debt decreased by $31.0 mln over the past reporting period (2.7% of market cap)
- FCF (LTM) +$0.0 bln (positive), 3.0% of market cap
- EV/EBITDA multiple is 221.2x compared to historical level (75th percentile) of 878.0x
- EV/Sales multiple is 4.3x

At the opening of the session the share price went down -0.1% vs S&P500 +0.3%

------------------------------------------------

2024-05-06

#reports #KRYS

[Krystal Biotech](https://eninvs.com/all.php?name=KRYS) (Medicine services provider) reported for 2024 q1
(2024-05-06, Before Market Open):

- Revenue +4400.0% YoY (vs +4100.0% in previous quarter and historical rate +50.0%)
- EBITDA margin -13.3% increased compared to -4800.0% same period last year
- Net Debt decreased by $14.0 mln over the past reporting period (0.3% of market cap)
- FCF (LTM) +$0.2 bln (positive), 4.2% of market cap
- EV/Sales multiple is 40.0x

At the opening of the session the share price went down -5.1% vs S&P500 +0.3%

------------------------------------------------

2024-05-06

#reports #JLL

[Jones Lang LaSalle](https://eninvs.com/all.php?name=JLL) (Real estate service provider) reported for 2024 q1
(2024-05-06, Before Market Open):

- Revenue +8.7% YoY (vs +4.9% in previous quarter and historical rate +9.2%)
- EBITDA +133.3% YoY (vs -14.1% in previous quarter and historical rate +29.5%)
- EBITDA margin 3.4% increased compared to 1.6% same period last year
- EV/EBITDA multiple is 10.2x compared to historical level (75th percentile) of 11.0x
- EV/Sales multiple is 0.4x

At the opening of the session the share price went up +5.2% vs S&P500 +0.3%

------------------------------------------------

2024-05-06

#reports #IART

[Integra LifeSciences](https://eninvs.com/all.php?name=IART) (Health care provider) reported for 2024 q1
(2024-05-06, Before Market Open):

- Revenue -3.1% YoY (vs -0.3% in previous quarter and historical rate +4.7%)
- EBITDA -50.0% YoY (vs -30.8% in previous quarter and historical rate -4.1%)
- EBITDA margin 8.7% decreased compared to 16.8% same period last year
- EV/EBITDA multiple is 11.1x compared to historical level (75th percentile) of 19.4x
- EV/Sales multiple is 1.8x

At the opening of the session the share price went down -15.3% vs S&P500 +0.3%

------------------------------------------------

2024-05-06

#reports #FRPT

[Freshpet](https://eninvs.com/all.php?name=FRPT) (Animal food manufacturer) reported for 2024 q1
(2024-05-06, Before Market Open):

- Revenue +33.3% YoY (vs +29.5% in previous quarter and historical rate +34.1%)
- EBITDA margin 10.3% increased compared to -4.2% same period last year
- Net Debt increased by $38.0 mln over the past reporting period (0.7% of market cap)
- FCF (LTM) -$0.1 bln (negative), 2.2% of market cap
- EV/EBITDA multiple is 151.7x compared to historical level (75th percentile) of 570.9x
- EV/Sales multiple is 6.6x

At the opening of the session the share price went up +8.8% vs S&P500 +0.3%

------------------------------------------------

2024-05-06

#reports #CLDT

[Chatham Lodging Trust](https://eninvs.com/all.php?name=CLDT) (Public real estate investment trust) reported for 2024 q1
(2024-05-06, Before Market Open):

- Revenue 0.0% YoY (vs +2.9% in previous quarter and historical rate +45.6%)
- EBITDA 0.0% YoY (vs -40.0% in previous quarter)
- EBITDA margin 23.5% has not changed compared to 23.5% same period last year
- EV/EBITDA multiple is 6.0x compared to historical level (75th percentile) of 14.5x
- EV/Sales multiple is 1.7x

At the opening of the session the share price went down -2.0% vs S&P500 +0.3%

------------------------------------------------

2024-05-06

#reports #BCRX

[BioCryst Pharmaceuticals](https://eninvs.com/all.php?name=BCRX) (Biotechnology) reported for 2024 q1
(2024-05-06, Before Market Open):

- Revenue +34.8% YoY (vs +16.3% in previous quarter and historical rate +89.9%)
- EBITDA margin -15.1% increased compared to -40.6% same period last year
- Net Debt increased by $86.0 mln over the past reporting period (9.6% of market cap)
- FCF (LTM) -$0.0 bln (negative), 1.6% of market cap
- EV/Sales multiple is 2.3x

At the opening of the session the share price went up +15.6% vs S&P500 +0.3%

------------------------------------------------

2024-05-06

#reports #AXSM

[Axsome Therapeutics](https://eninvs.com/all.php?name=AXSM) (Treatments for neurological disorders developer) reported for 2024 q1
(2024-05-06, Before Market Open):

- Revenue -21.1% YoY (vs +200.0% in previous quarter and historical rate +114.9%)
- EBITDA margin -89.3% decreased compared to -6.3% same period last year
- Net Debt increased by $57.0 mln over the past reporting period (1.6% of market cap)
- FCF (LTM) +$0.1 bln (positive), 3.7% of market cap
- EV/Sales multiple is 12.8x

At the opening of the session the share price went down -0.5% vs S&P500 +0.3%

------------------------------------------------

2024-05-06

#reports #SAVE
@ airlines

[Spirit Airlines](https://eninvs.com/all.php?name=SAVE) (Airline) reported for [2024 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=167726)
(2024-05-06, Before Market Open):

- Revenue -6.2% YoY (vs -5.0% in previous quarter and historical rate +59.2%)
- EBITDA margin -7.1% decreased compared to -2.5% same period last year
- EV/Sales multiple is 1.2x

The company showed EPS -$1.30 per share. At the opening of the session the share price went down -9.7% vs S&P500 +0.3%

------------------------------------------------

2024-05-04

#reports #SSB

[South State](https://eninvs.com/all.php?name=SSB) (Banking service provider) reported for [2024 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=167593)
(2024-04-25, After Market Close):

- Revenue -9.7% YoY (vs -10.6% in previous quarter and historical rate +1.8%)
- Net Income -17.9% YoY (vs -25.7% in previous quarter and historical rate +22.1%)
- Net Income margin 33.4% decreased compared to 36.7% same period last year
- P/E multiple is 12.7x compared to historical level (75th percentile) of 12.7x
- P/S multiple is 4.2x
- Price to book: 1.1x

The company showed EPS +$1.50 per share. At the opening of the session the share price went down -1.7% vs S&P500 +0.7%

------------------------------------------------

2024-05-04

#reports #SHIP

[Seanergy Maritime](https://eninvs.com/all.php?name=SHIP) (Marine Shipping) reported for 2023 q4
(2023-08-02, Before Market Open):

- Revenue +34.5% YoY (vs -29.4% in previous quarter and historical rate +42.1%)
- EBITDA margin 56.4% increased compared to -10.3% same period last year
- Net Debt increased by $17.0 mln over the past reporting period (9.7% of market cap)
- FCF (LTM) +$0.0 bln (positive), 25.7% of market cap
- EV/EBITDA multiple is 11.9x compared to historical level (75th percentile) of 44.3x
- EV/Sales multiple is 3.6x

The company showed EPS +$0.55 per share. At the opening of the session the share price went down -2.1% vs S&P500 -0.6%

------------------------------------------------

2024-05-04

#reports #OFLX

[Omega Flex](https://eninvs.com/all.php?name=OFLX) (Specialty Industrial Machinery) reported for [2024 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=167621)
(2024-03-04, After Market Close):

- Revenue -16.7% YoY (vs -9.7% in previous quarter and historical rate -0.2%)
- EBITDA -37.5% YoY (vs -25.0% in previous quarter and historical rate -3.6%)
- EBITDA margin 20.0% decreased compared to 26.7% same period last year
- Net Debt increased by $1.0 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) +$0.0 bln (positive), 1.5% of market cap
- EV/EBITDA multiple is 26.3x compared to historical level (75th percentile) of 34.3x
- EV/Sales multiple is 6.0x

The company showed EPS +$0.42 per share. At the opening of the session the share price went down -1.3% vs S&P500 -0.4%

Switch to company model in "Rising Stars" logic    *